Anebulo was founded with the intention of developing disruptive treatments for substance use disorders, such as cannabinoid intoxication and the broader addiction landscape.

Pharmaceutical

Anebulo Pharmaceuticals

Simon Allen

Kenneth Cundy

Sandra Gardiner

The Leadership Team at Anebulo Pharmaceuticals drives the overall strategic vision and direction of the company, focusing on innovative solutions for substance use disorders. Comprising the CEO, Chief Scientific Officer, and Acting CFO, this team oversees research initiatives, financial stewardship, and corporate governance, ensuring that the company's mission to develop disruptive treatments is realized efficiently and effectively.

Leadership Team

About

Team members

Other teams at Anebulo Pharmaceuticals

Scientific Advisory Team